Rockwell Medical Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/30/2026)
| Balance Sheet | Total Assets | 57,145,000.00 | ROE | 64.71 % |
| Balance Sheet | Total Equity | 36,981,000.00 | ROA | -9.30 % |
| Cashflow | Capital Expenditures | -1.00 | P/FCF | -418.15 |
| Cashflow | Free Cash Flow | -659,000.00 | – | – |
| Cashflow | Operating Cash Flow | -659,000.00 | P/CF | -418.15 |
| Income | Earnings per Share (diluted) | -0.15 | Div. Yield | – |
| Income | Net Income | -5,314,000.00 | P/E | -51.07 |
| Income | Shares Outstanding | 35,974,200.00 | P/B | 7.45 |
| Income | Total Revenue | 69,258,000.00 | P/S | 3.98 |
Ratios calculated on: 10/14/2026
Company Description
Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient´s bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.rockwellmed.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more